Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.57 |
| ▸ | PLA2G4B | P0C869 | 4/20 | 0.55 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.54 |
| ▸ | THRA | P10827 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CYSLTR2 | Q9NS75 | 3/20 | 0.49 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.49 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8766568 | 1.00 | TSHR (0.65) | TSHRSMPD1PLA2G4BGGPS1THRA | |
| SCHEMBL1665036 | 1.00 | TSHR (0.65) | TSHRSMPD1PLA2G4BGGPS1THRA | |
| SCHEMBL9717879 | 1.00 | TSHR (0.65) | TSHRSMPD1PLA2G4BGGPS1THRA | |
| SCHEMBL7297045 | 0.98 | TSHR (0.62) | TSHRSMPD1PLA2G4BGGPS1THRA | |
| SCHEMBL1805409 | 0.93 | TSHR (0.54) | TSHRSMPD1PLA2G4BTHRBLTA4H | |
| SCHEMBL8765681 | 0.91 | KMT2A (0.61) | TSHRSMPD1PLA2G4BGGPS1KMT2A | |
| SCHEMBL1804312 | 0.87 | KMT2A (0.59) | TSHRSMPD1KMT2ACYSLTR1 | |
| SCHEMBL4208924 | 0.87 | TSHR (0.76) | TSHRSMPD1PLA2G4BGGPS1THRA | |
| SCHEMBL6677146 | 0.87 | TSHR (0.76) | TSHRSMPD1PLA2G4BGGPS1THRA | |
| SCHEMBL17138169 | 0.87 | TSHR (0.76) | TSHRSMPD1PLA2G4BGGPS1THRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1975160-B1 | Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method | FUJIFILM CORP (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-8173226-B2 | Polymerizable compound , polyethylene glycol mono(meth)acrylate, a polystyrene oligomer having a methacryloyl group at one terminal, acrylic macromonomer imides | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20090214797-A1 | INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| EP-2093265-A1 | Inkjet ink composition, and inkjet recording method and printed material employing same | FUJIFILM Corporation (JP) | 2009-08-26 | — | — | EP | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080241416-A1 | POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| EP-1975160-A1 | Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method | Fujifilm Corporation (JP) | 2008-10-01 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-7022823-B2 | Diazonium salt, its synthesizing method and recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2006-04-04 | — | — | US | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| US-20040039180-A1 | Diazonium salt, its synthesizing method and recording material | FUJI PHOTO FILM CO., LTD. | 2004-02-26 | — | — | US | disclosed |
| US-6433223-B1 | HYDROXYLAMINE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 2002-08-13 | — | — | US | disclosed |
| US-6057090-A | Silver halide photographic material and hydroxamic acid-based compound used therefor | FUJI PHOTO FILM CO., LTD. (JP) | 2000-05-02 | — | — | US | disclosed |
| EP-0698814-B1 | Silver halide photographic material with improved latent image stability | FUJI PHOTO FILM CO LTD (JP) | 1998-11-25 | — | — | EP | disclosed |
| US-5840886-A | Silver halide photographic material and hydroxamic acid based compound used therefore | FUJI PHOTO FILM CO., LTD. (JP) | 1998-11-24 | — | — | US | disclosed |
| EP-0819672-A2 | Hydroxamic acid derivatives and their use for improving latent image stability of a silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1998-01-21 | — | — | EP | disclosed |
| US-5667959-A | Silver halide photographic material and hydroxamic acid based compound used therefor | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-16 | — | — | US | disclosed |
| EP-0698814-A2 | Silver halide photographic material with improved latent image stability | FUJI PHOTO FILM CO., LTD. (JP) | 1996-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241416-A1 | POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD | CNOT1, CCNT1, SCO2 | TSHR 4636/4885SMPD1 4581/4885PLA2G4B 3555/4885 |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | TSHR 162/4885SMPD1 4405/4885PLA2G4B 4285/4885 |
| US-20040039180-A1 | Diazonium salt, its synthesizing method and recording material | CACNA1E, HCN2, HCN1 | TSHR 1663/4885SMPD1 1901/4885PLA2G4B 4465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.